Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. General Hospital "Dr. Josip Benčević" Slavonski Brod

Source: Site record.

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The General Hospital “Dr. Josip Benčević” Slavonski Brod is a regional secondary-to-tertiary care hospital in Croatia with emerging potential for clinical research across multiple therapeutic areas. Affiliated with the Faculty of Medicine University of Osijek, it integrates clinical care with education and research, supporting a structured academic environment for conducting studies. The hospital provides a wide range of services including inpatient and outpatient care, diagnostics, intensive care, and laboratory support, enabling management of diverse patient populations. Its multidisciplinary capabilities span areas such as cardiology, oncology, neurology, infectious diseases, hematology, and surgery, which are relevant for both interventional and observational trials. Additionally, its role as a key healthcare provider in the Slavonia region ensures steady patient inflow and access to varied disease profiles, supporting recruitment and longitudinal follow-up. The hospital has…

Source: Trial-derived.
12Total Trials
Source: Trial-derived.
1Recruiting Trials
Source: Trial-derived.
4Active Trials
Source: Trial-derived.
8Completed Trials
Source: Trial-derived.
16Unique Conditions
Source: Trial-derived.
23Unique Sponsors

Conditions

Source: Trial-derived. Diabetes Mellitus, Type 2 (3)Source: Trial-derived. Ventilator Associated Pneumonia (3)Source: Trial-derived. Acute Coronary Syndrome (1)Source: Trial-derived. Complicated Intra-abdominal Infection (1)Source: Trial-derived. Coronary Artery Disease (1)Source: Trial-derived. Diffuse Large B-Cell Lymphoma (1)Source: Trial-derived. Hospital-acquired Pneumonia (1)Source: Trial-derived. Hosptial Acquired Pneumonia (1)

Sponsors

Source: Trial-derived. Novo Nordisk A/S (3)Source: Trial-derived. AbbVie (1)Source: Trial-derived. Biomedical Advanced Research and Development Authority (1)Source: Trial-derived. Bristol-Myers Squibb (1)Source: Trial-derived. CEL-SCI Corporation (1)Source: Trial-derived. Centre Hospitalier Universitaire Dupuytren de Limoges (CHUL) (1)Source: Trial-derived. Eli Lilly and Company (1)Source: Trial-derived. European Clinical Research Alliance for Infectious Diseases (ECRAID) (1)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Continuous glucose monitoring

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Ophthalmological retinopathy examination